Name: Icrp Publication 128: Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances (Annals of the Icrp)
Price: 5217.00 ZAR
Availability: InStock
Author: Clement C. H. (Edt); Hamada N. (Edt); Mattsson S.; Johansson L.; Svegborn S. Leide
ISBN: 9781473939479

portada Icrp Publication 128: Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances (Annals of the Icrp)

Icrp Publication 128: Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances (Annals of the Icrp)

Type

Physical Book

Publisher

Sage Publications Ltd

Author

Clement C. H. (Edt); Hamada N. (Edt); Mattsson S.; Johansson L.; Svegborn S. Leide

Language

English

Pages

322

Format

Paperback

ISBN13

9781473939479

Edition No.

Icrp Publication 128: Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances (Annals of the Icrp)

Clement C. H. (Edt); Hamada N. (Edt); Mattsson S.; Johansson L.; Svegborn S. Leide (Author) · Sage Publications Ltd · Paperback

Cheaper New Book Imported to South Africa

Delivery: 17 Aug - 28 Aug

R 5,217

Faster New Book Imported to South Africa

Delivery: 19 Aug - 27 Aug

R 5,846

R 5,217

Add to Wishlist

Synopsis "Icrp Publication 128: Radiation Dose to Patients From Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances (Annals of the Icrp) "

This report provides a compendium of current information relating to radiation dose to patients, including biokinetic models, biokinetic data, dose coefficients for organ and tissue absorbed doses, and effective dose for major radiopharmaceuticals based on ICRP radiation protection guidance. These data were compiled from ICRP Publications 53, 80, and 106 and related amendments and corrections. This report also includes new information for 82Rb-chloride, iodide (123I, 124I, 125I, and 131I) and 123I labelled 2 -carbomethoxy 3 -(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT). The data presented in this report are intended for diagnostic nuclear medicine and not for therapeutic applications.